Enhanced Oncolysis by a Tropism-Modified Telomerase-Specific Replication-Selective Adenoviral Agent OBP-405 (‘Telomelysin-Rgd’)

Oncogene - United Kingdom
doi 10.1038/sj.onc.1208460
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Selective Ablation of Human Cancer Cells by Telomerase-Specific Adenoviral Suicide Gene Therapy Vectors Expressing Bacterial Nitroreductase

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Antitumor Effects of Telomerase-Specific Replication-Selective Oncolytic Viruses for Adenoid Cystic Carcinoma Cell Lines

Oncology Reports
MedicineCancer ResearchOncology
2013English

Enhanced Transduction of Malignant Glioma With a Double Targeted Ad5/3-RGD Fiber-Modified Adenovirus

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Persistent, Antigen-Specific, Therapeutic Antitumor Immunity by Dendritic Cells Genetically Modified With an Adenoviral Vector to Express a Model Tumor Antigen

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

Differences in Transductional Tropism of Adenoviral and Lentiviral Vectors in the Rat Brainstem

Experimental Physiology
NutritionPhysiologyDietetics
2004English

Prognostic Impact of Detecting Viable Circulating Tumour Cells in Gastric Cancer Patients Using a Telomerase-Specific Viral Agent: A Prospective Study

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Tamoxifen-Regulated Adenoviral E1A Chimeras for the Control of Tumor Selective Oncolytic Adenovirus Replication in Vitro and in Vivo

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2005English

842. Increased Oncolytic Ability of a Double RGD-Modified Adenovirus in Ovarian Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Selective Inhibition of Human Cytomegalovirus Replication by a Novel Nucleoside, Oxetanocin G.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy